FDA Approved: DICLOFENAC SODIUM — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved a supplemental application for diclofenac sodium from Aurobindo Pharma Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Dental Pain
• Dysmenorrhea
• Migraine
• Osteoarthritis
• Pain
• Rheumatoid Arthritis

Drugs mentioned

• DICLOFENAC SODIUM (DICLOFENAC SODIUM)

Snippet

SUPPL AP for DICLOFENAC SODIUM (DICLOFENAC SODIUM)